Watch the discount on India's CV pipeline

The Hong Kong private equity forum delivered a simple instruction to the secondaries market: watch the discount. Panelists there expect Indian sponsors to run secondaries exits ahead of fundraises, a sequencing that pushes continuation-vehicle supply straight onto GP-led desks at the moment the buyout benchmark has turned negative, and that combination—supply that cannot wait, a benchmark that can no longer be ignored—changes who sets the price.

The arithmetic behind that instruction is distribution pressure: Indian limited partners have absorbed years of mark-to-market gains while distributions lagged, and sponsors returning to raise new funds now face the same question LPs are asking everywhere—show us cash before you ask for commitments. The Hong Kong panelists described that pressure as DPI-driven and made the sequencing explicit: secondaries exits will come before Indian fundraises, an order that matters because it removes the sponsor's usual option of waiting for a better mark.

The Indian DPI problem has a specific flavor: many sponsors marked portfolios through a venture-growth cycle that has not produced the exits to validate those marks, so LPs saw net asset values rise while distributions stayed thin. That leaves a liquidity gap, and secondaries exits are the fastest way to close it. The Hong Kong panelists' expectation reflects a judgment about liquidity: the next fundraise depends on returning cash, not marking another unrealized gain.

HarbourVest's first-quarter global buyout return turned negative, and that single data point rewrites the underwrite for every continuation vehicle. It lands hardest on Indian assets because it gives limited partners a public index to hold against a sponsor's marks. When the benchmark is positive, an 11x continuation can look like a discount to what a public listing might eventually deliver. When the benchmark is negative, the same multiple is a premium that has to be defended with cash flow, not narrative.

Recent GP-led prints show how that negotiation has been clearing: Bridgepoint and Pantheon's Saviynt continuation rolled at 11x, Pantheon led a €1.2 billion Bridgepoint Credit continuation, StepStone led one for Core Health & Fitness, Kelso closed a $510 million continuation for a Utah MEP contractor, and Hudson Hill closed a single-asset vehicle for InXpress. These deals demonstrate that demand for quality secondaries assets remains deep, but they also set the reference points against which the next Indian CV will be measured.

India is where the two forces collide: the Hong Kong panelists' call that secondaries exits will precede fundraises turns a trickle of Indian continuation vehicles into a pipeline that must get done, and when supply is pipeline-driven, the sponsor loses control of timing. The buyer can price across the entire cohort rather than each asset in isolation, and a global buyout benchmark that has just turned negative gives the buyer the language to do exactly that.

This is where the Saviynt and Bridgepoint Credit prints become more than points of comparison. Those deals were club-level clears with named buyers, long diligence, and sponsors who could afford to say no, but an Indian CV pipeline arriving in bulk will not get the same treatment. Each mandate will compete with every other Indian GP trying to print before year-end, and each buyer will run the same comparison to the HarbourVest benchmark. The question in every pricing session will be why an Indian sponsor's mark should sit above the global buyout index's latest print.

The answer, increasingly, will be that it should not. India is likely to become the first market where sponsors are forced to sell below their marks to create liquidity, a function of the changed bargaining structure in which the seller needs the close to go back to LPs with cash and the buyer can wait or walk to the next deal. That asymmetry is not new, but the negative benchmark makes it visible and measurable.

There is a second consequence: if Indian continuation vehicles clear at discounts, those prints become comparable data for LPs in other emerging markets, and a Singapore LP will not accept a full-price continuation from a Southeast Asian sponsor once an Indian GP has been forced to sell below its mark. The discount, once established in one market, travels, which is the real meaning of the instruction from Hong Kong—the secondaries market is being asked to set a new price floor, and India is the first place it will be tested.

Not everyone on the GP-led desk will be surprised. Buyers who have underwritten Indian growth for years know that sponsor marks were run on assumptions that public comps did not always support, and what has been missing is a public data point with enough weight to force the conversation. HarbourVest's negative first-quarter return is that point; it needs only to be citable in a limited partner's committee memo when a sponsor asks for a continuation at 11x.

The first read will come not from which Indian CV closes first but from the discount it clears at. The Hong Kong forum gave buyers permission to make that the first question, and sponsors who still believe they can price their own continuations at the levels Saviynt and Bridgepoint Credit achieved are likely to find the market has moved beneath them. The secondaries desk is no longer underwriting India on the sponsor's terms, so the next Indian continuation print will show how far the discount has to go.